Loading...
Synergistic effects of olaparib combined with ERCC1 on the sensitivity of cisplatin in non-small cell lung cancer
Non-small cell lung cancer (NSCLC) is a common malignant tumor. ERCC excision repair 1 endonuclease non-catalytic subunit (ERCC1) is a key mediator of nucleotide excision repair. The present study aimed to explore the synergistic effects of the poly(ADP-ribose) polymerase (PARP) inhibitor olaparib c...
Na minha lista:
| Udgivet i: | Oncol Lett |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
D.A. Spandidos
2021
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7967929/ https://ncbi.nlm.nih.gov/pubmed/33747222 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2021.12626 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|